Edition:
United States

OHR Pharmaceutical Inc (OHRP.OQ)

OHRP.OQ on NASDAQ Stock Exchange Capital Market

1.58USD
15 Dec 2017
Change (% chg)

$-0.13 (-7.60%)
Prev Close
$1.71
Open
$1.71
Day's High
$1.74
Day's Low
$1.42
Volume
603,912
Avg. Vol
148,028
52-wk High
$1.90
52-wk Low
$0.57

Chart for

About

Ohr Pharmaceutical, Inc. is a pharmaceutical company focused on the development of therapeutics and delivery technologies for the treatment of ocular disease. The Company's development pipeline consists of several programs and indications at various stages of development. Its product pipeline includes Squalamine Lactate... (more)

Overall

Beta: 0.32
Market Cap(Mil.): $88.81
Shares Outstanding(Mil.): 56.21
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 198.20 16.04
EPS (TTM): -- -- --
ROI: -- -11.76 34.69
ROE: -- -36.72 15.46

BRIEF-OHR Pharmaceutical Reports Fiscal Year 2017 Financial Results

* OHR PHARMACEUTICAL REPORTS FISCAL YEAR 2017 FINANCIAL RESULTS

Dec 15 2017

BRIEF-Ohr Pharmaceutical files for mixed shelf of up to $250 mln

* Files for mixed shelf of up to $250 million - SEC filing‍​ Source text: (http://bit.ly/2x8VRBB) Further company coverage:

Sep 15 2017

BRIEF-OHR Pharmaceutical Q3 loss per share $0.07

* OHR Pharmaceutical announces fiscal third quarter 2017 earnings

Aug 08 2017

Competitors

  Price Chg
Roche Holding Ltd. (ROG.S) CHF244.10 +2.40
Roche Holding Ltd. (RO.S) CHF243.40 +0.90
Regeneron Pharmaceuticals Inc (REGN.OQ) $388.95 +5.83
Amgen, Inc. (AMGN.OQ) $177.04 +2.12
Novartis AG (NOVN.S) CHF83.80 -0.05
Allergan plc (AGN.N) $171.68 +0.74

Earnings vs. Estimates